首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
AtezolizumabThrombotic microangiopathy: 2 case reports
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2021年
/ 1854卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-021-95397-8
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:66 / 66
相关论文
共 50 条
[21]
Gemcitabine/pazopanibPodocytopathy and thrombotic microangiopathy: 2 case reports
Reactions Weekly,
2023,
1971
(1)
: 123
-
123
[22]
TacrolimusPancreatic dysfunction and thrombotic microangiopathy: 2 case reports
Reactions Weekly,
2022,
1919
(1)
: 558
-
558
[23]
ImmunosuppressantsTransplant associated thrombotic microangiopathy: 2 case reports
Reactions Weekly,
2017,
1670
(1)
: 154
-
154
[24]
Cotrimoxazole/tacrolimusCytopenia and thrombotic microangiopathy: 2 case reports
Reactions Weekly,
2022,
1937
(1)
: 175
-
175
[25]
TacrolimusTransplantation-associated microangiopathy: 2 case reports
Reactions Weekly,
2022,
1913
(1)
: 400
-
400
[26]
CyclosporinDepression associated with thrombotic microangiopathy: 2 case reports
Reactions Weekly,
1999,
752
(1)
: 8
-
8
[27]
TacrolimusThrombotic microangiopathy successfully treated with eculizumab: 2 case reports
Reactions Weekly,
2017,
1648
(1)
: 278
-
278
[28]
Cyclophosphamide/eculizumabThrombotic microangiopathy and lack of efficacy: 2 case reports
Reactions Weekly,
2023,
1976
(1)
: 118
-
118
[29]
SunitinibThrombotic microangiopathy, cerebral infarction and hypertension: 2 case reports
Reactions Weekly,
2023,
1979
(1)
: 438
-
438
[30]
BevacizumabThrombotic microangiopathy or acute tubular necrosis: 2 case reports
Reactions Weekly,
2022,
1905
(1)
: 124
-
124
←
1
2
3
4
5
→